Domov › Sladkorna bolezen tipa 2 › Kentucky
Klinične študije za Sladkorna bolezen tipa 2 v Kentucky
12 študij za Sladkorna bolezen tipa 2 išče udeležence na lokacijah v Kentucky.
Mesta v Kentucky
Uradno besedilo študije (angleško)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Qualmedica Research - Bowling Green, Bowling Green
- The Research Group of Lexington, Lexington
- Research Integrity, LLC, Owensboro
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- AMR Lexington, Lexington
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07754461A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- St Elizabeth Health Care - CRI, Edgewood
- UofL Health, Louisville
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 55 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06112418A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Monroe Biomedical Research, Louisville
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07595549A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Bowling Green
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- St. Elizabeth Healthcare, Edgewood
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07296484AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- The Research Group of Lexington LLC, Lexington
Vključevanje udeležencevFaza 3
Starost 45 in več · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Lexington
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT07662044A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Norton Children's Endocrinology, Louisville
Vključevanje udeležencevFaza 3
Starost 10–17 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06739122Time-restricted Eating for Patients With Type 2 Diabetes
- University of Kentucky Barnstable Brown Diabetes Center, Lexington
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 31. jul. 2026 · NCT07318207OASIS: Peer Support for T2DM in Appalachia (Peer Participant)
- Barren River Area Development District, Bowling Green
- UK HealthCare, Hazard
Vključevanje udeležencev
Starost 55 in več · Vsi spoli · Posodobljeno 17. jun. 2026 · NCT06336122OASIS: Peer Support for T2DM in Appalachia (Peer Coaches)
- Barren River Area Development District, Bowling Green
- UK HealthCare, Hazard
Vključevanje udeležencev
Starost 55 in več · Vsi spoli · Posodobljeno 17. jun. 2026 · NCT06003634Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.